Small Molecule Induced FLT3 Degradationopen access
- Authors
- Han, Sun-Young
- Issue Date
- Mar-2022
- Publisher
- MDPI
- Keywords
- fms-like tyrosine kinase 3; target protein degrader; heat shock protein 90; ubiquitin proteasome system
- Citation
- PHARMACEUTICALS, v.15, no.3
- Indexed
- SCIE
SCOPUS
- Journal Title
- PHARMACEUTICALS
- Volume
- 15
- Number
- 3
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/1586
- DOI
- 10.3390/ph15030320
- ISSN
- 1424-8247
1424-8247
- Abstract
- Target protein degrader is a new paradigm in the small molecule drug discovery field and relates to the term 'event-driven pharmacology'. Fms-like tyrosine kinase 3 (FLT3) is a significant target for treating acute myeloid leukemia (AML). A few FLT3 kinase inhibitors are currently used in the clinic for AML patients. However, resistance to current FLT3 inhibitors has emerged, and strategies to overcome this resistance are required. Small molecules downregulating FLT3 protein level are reported, exhibiting antileukemic effects against AML cell lines. Small molecules with various mechanisms such as Hsp90 inhibition, proteasome inhibition, RET inhibition, and USP10 inhibition are explained. In addition, reports of FLT3 as a client of Hsp90, current knowledge of the ubiquitin proteasome system for FLT3 degradation, the relationship with FLT3 phosphorylation status and susceptibility of FLT3 degradation are discussed.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 약학대학 > 약학과 > Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.